期刊文献+

MicroRNA-144在结肠癌中的表达水平及临床意义 被引量:6

Clinical significance of microRNA-144 expression in colon tumor
下载PDF
导出
摘要 目的探讨microRNA-144在结肠癌中的表达水平及其与临床病理特征的相关性。方法提取38例结肠癌及其正常结肠黏膜组织标本的总RNA,采用逆转录实时荧光定量聚合酶链反应(RT-qPCR)方法检测microRNA-144的表达量,并分析其与临床分期、分化程度、淋巴结转移等临床病理特征的关系。结果癌与癌旁正常结肠黏膜组织比较,microRNA-144在癌组织中高表达,相对表达量的中位数是2.30。其表达与TNM分期(P<0.05)、分化程度(P<0.05)相关,受试者工作特征(ROC)曲线分析显示,以相对表达量1.70为临界点时,microRNA-144作为评价结肠癌细胞分化程度,敏感性为88%,特异性为61.5%。结论 microRNA-144在结肠癌中的异常表达可能与结肠癌的发生、发展有关。 Objective To investigate the expression of microRNA-144 and its association with clinic-pathological features in colon tumor.Methods The expression levels of microRNA-144 in 38 colon tumors and their matched non-tumor adjacent tissue specimens were detected by using stem-loop real-time reverse transcription-polymerase chain reaction(RT-qPCR),and their correlation with clinic-pathologic features of colon tumor was analyzed.Results Expression levels of microRNA-144 were significantly higher in tumor tissues than in adjacent normal tissues(P0.05),the median of comparative expression level was 2.30.The expression of microRNA-144 was associated with TNM stage(P0.05)and cell differentiation(P0.05).ROC curve of microRNA-144 about cell differentiation and resulted in a diagnostic sensitivity of 88% and specificity of 61.3%.Conclusion The level of microRNA-144 expression may be a valuable adjuvant parameter in forecasting the poorly differentiated colon tumor.
出处 《重庆医学》 CAS CSCD 北大核心 2013年第22期2594-2596,共3页 Chongqing medicine
关键词 microRNA-144 结肠癌 细胞分化 淋巴结转移 microRNA-144 colon tumor cell differentiation lymphatic metastasis
  • 相关文献

参考文献11

  • 1Cho WC. OncomiRs: the discovery and progress of mi-croRNAs in cancers[J]. Mol Cancer, 2007,6 .. 60-65.
  • 2Gabriely G, Wurdinger T, Kesari S, et al. MicroRNA 21 pro- motes glioma invasion by targeting matrix metalloproteinase regulators[J]. Mol Cell Biol, 2008,28 (17) : 5369-5380.
  • 3Wang R,Wang ZX,Yang JS,et al. MieroRNA-451 func- tions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)[J]. Oncogene, 2011,30(23) : 2644-2658.
  • 4Kent OA,Chivukula RR, Mullendore M, et al. Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway[J]. Genes Dev, 2010,24(24) .. 2754-2759.
  • 5Douillard JY, Siena S, Cassidy J, et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, ieu- covorin, and oxaliplatin(FOLFOX4) versus FOLFOX4 a- lone as first-line treatment in patients with previously un- treated metastatic colorectal cancer: the PRIME study[J]. J Clin Oncol,2010,28(31) :4697-4705.
  • 6Lee I, Ajay SS, Yook JI, et al. New class of microRNA targets containing simultaneous 5'-UTR and 3'-UTR in- teraction sites[J]. Genome Res,2009,19(7) :1175-1183.
  • 7Slaby O,Svoboda M, Michalek J, et al. MieroRNAs in eolor- ectal cancer: translation of molecular biology into clinical ap- plication[J]. Mol Cancer, 2009,8 .. 102-115.
  • 8Kalimutho M,Del VBG,Di Cecilia S,et al. Differential ex- pression of miR-144 as a novel fecal-based diagnostic marker for colorectal cancer[J]. J Gastroenterol, 2011,46 (12) ..1391-1402.
  • 9Slattery ML, Wolff E, Hoffman MD, et al. MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype [J]. Genes Chromosomes Cancer,2011,50(3) :196-206.
  • 10Schepeler T, Reinert JT, Ostenfeld MS, et al. Diagnostic and prognostic microRNAs in stage II colon eancer[J]. Cancer Res, 2008,68 ( 15 ) .. 6416-6424.

同被引文献35

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部